362 related articles for article (PubMed ID: 35214702)
1. The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?
De Francesco MA; Caruso A
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214702
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
3. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
[No Abstract] [Full Text] [Related]
4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach.
Hedin CRH; Sonkoly E; Eberhardson M; Ståhle M
J Intern Med; 2021 Aug; 290(2):257-278. PubMed ID: 33942408
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis and inflammatory bowel disease: links and risks.
Vlachos C; Gaitanis G; Katsanos KH; Christodoulou DK; Tsianos E; Bassukas ID
Psoriasis (Auckl); 2016; 6():73-92. PubMed ID: 29387596
[TBL] [Abstract][Full Text] [Related]
7. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
[TBL] [Abstract][Full Text] [Related]
8. Diet and gut microbiota manipulation for the management of Crohn's disease and ulcerative colitis.
Svolos V; Gkikas K; Gerasimidis K
Proc Nutr Soc; 2021 Sep; ():1-15. PubMed ID: 34551834
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases.
Zhou Y; He Y; Liu L; Zhou W; Wang P; Hu H; Nie Y; Chen Y
Front Nutr; 2021; 8():615064. PubMed ID: 33718417
[TBL] [Abstract][Full Text] [Related]
10. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease.
Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease.
Sankarasubramanian J; Ahmad R; Avuthu N; Singh AB; Guda C
Front Med (Lausanne); 2020; 7():606298. PubMed ID: 33330572
[No Abstract] [Full Text] [Related]
12. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
13. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
[TBL] [Abstract][Full Text] [Related]
14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome.
Shahini A; Shahini A
J Cell Commun Signal; 2023 Mar; 17(1):55-74. PubMed ID: 36112307
[TBL] [Abstract][Full Text] [Related]
16. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review.
Wark G; Samocha-Bonet D; Ghaly S; Danta M
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396537
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
[TBL] [Abstract][Full Text] [Related]
18. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease.
Segal JP; Mullish BH; Quraishi MN; Acharjee A; Williams HRT; Iqbal T; Hart AL; Marchesi JR
Therap Adv Gastroenterol; 2019; 12():1756284818822250. PubMed ID: 30719076
[TBL] [Abstract][Full Text] [Related]
19. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
20. Host-microbial Cross-talk in Inflammatory Bowel Disease.
Nagao-Kitamoto H; Kamada N
Immune Netw; 2017 Feb; 17(1):1-12. PubMed ID: 28261015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
